Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma

NCT02565173 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma (POAG)
Ocular Hypertension (OHT)

Interventions

DRUG: trabodenoson 4.5% BID
DRUG: trabodenoson 6.0% QD
DRUG: trabodenoson 3.0% QD
DRUG: timolol 0.5% BID
DRUG: placebo BID

Sponsor

Inotek Pharmaceuticals Corporation